Lindbrook Capital’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-286
Closed -$426 2875
2024
Q3
$426 Buy
+286
New +$424 ﹤0.01% 2708
2024
Q1
Sell
-2,940
Closed -$4.44K 2728
2023
Q4
$4.44K Sell
2,940
-5,917
-67% -$8.55K ﹤0.01% 1948
2023
Q3
$14.2K Sell
8,857
-2,023
-19% -$3.69K ﹤0.01% 1232
2023
Q2
$23.6K Buy
10,880
+752
+7% +$1.18K ﹤0.01% 1001
2023
Q1
$14.8K Buy
10,128
+7,569
+296% +$9.74K ﹤0.01% 1216
2022
Q4
$3.2K Buy
2,559
+1,858
+265% +$2.93K ﹤0.01% 2024
2022
Q3
$1K Buy
701
+179
+34% +$423 ﹤0.01% 2437
2022
Q2
$1K Sell
522
-615
-54% -$1.79K ﹤0.01% 2314
2022
Q1
$4K Buy
1,137
+137
+14% +$484 ﹤0.01% 1727
2021
Q4
$5K Hold
1,000
﹤0.01% 1516
2021
Q3
$4K Hold
1,000
﹤0.01% 1329
2021
Q2
$4K Hold
1,000
﹤0.01% 1384
2021
Q1
$4K Hold
1,000
﹤0.01% 1345
2020
Q4
$4K Hold
1,000
﹤0.01% 1265
2020
Q3
$4K Hold
1,000
﹤0.01% 1191
2020
Q2
$3K Hold
1,000
﹤0.01% 1279
2020
Q1
$1K Hold
1,000
﹤0.01% 1519
2019
Q4
$1K Hold
1,000
﹤0.01% 1422
2019
Q3
$2K Hold
1,000
﹤0.01% 1288
2019
Q2
$2K Hold
1,000
﹤0.01% 1254
2019
Q1
$2K Hold
1,000
﹤0.01% 1249
2018
Q4
$3K Buy
+1,000
New +$3.39K ﹤0.01% 1121

Other funds holding OPK

Lindbrook Capital's OPK Position: Q4 2024 in Review

Lindbrook Capital sold out of Opko Health (OPK) in Q4 2024, closing a stake of 286 shares — an estimated $426 sold.

Lindbrook Capital first reported a position in OPK in Q4 2018 and held it in 22 quarters. The position peaked at $23.6K in Q2 2023. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Lindbrook Capital reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 286 Opko Health shares in Q4 2024, an estimated $426.
  • Lindbrook Capital first reported a position in Opko Health in Q4 2018 and held it in 22 quarters.
  • Lindbrook Capital's Opko Health position peaked at $23.6K in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.